Clinical trials
Phase 2 trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5,181 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 47 |
| 2001 | 52 |
| 2002 | 69 |
| 2003 | 91 |
| 2004 | 109 |
| 2005 | 166 |
| 2006 | 215 |
| 2007 | 217 |
| 2008 | 226 |
| 2009 | 223 |
| 2010 | 245 |
| 2011 | 246 |
| 2012 | 230 |
| 2013 | 190 |
| 2014 | 211 |
| 2015 | 207 |
| 2016 | 203 |
| 2017 | 213 |
| 2018 | 214 |
| 2019 | 239 |
| 2020 | 169 |
| 2021 | 288 |
| 2022 | 210 |
| 2023 | 195 |
| 2024 | 226 |
| 2025 | 228 |
| 2026 | 144 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3,229 |
| Terminated | 739 |
| Recruiting | 449 |
| Active, not recruiting | 364 |
| Unknown status | 226 |
| Withdrawn | 101 |
| Not yet recruiting | 54 |
| Enrolling by invitation | 11 |
| Suspended | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 222 |
| Novartis Pharmaceuticals | 165 |
| GlaxoSmithKline | 162 |
| Pfizer | 159 |
| National Cancer Institute (NCI) | 128 |
| AstraZeneca | 118 |
| Hoffmann-La Roche | 105 |
| Bristol-Myers Squibb | 104 |
| Sanofi | 89 |
| Boehringer Ingelheim | 88 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 173 |
| Carcinoma, Non-Small-Cell Lung | 162 |
| Prostatic Neoplasms | 141 |
| Neoplasms | 129 |
| Diabetes Mellitus, Type 2 | 106 |
| Dermatitis, Atopic | 98 |
| Asthma | 93 |
| Ovarian Neoplasms | 88 |
| Colorectal Neoplasms | 77 |
| Alzheimer Disease | 75 |
Trials
Showing 1 to 25 of 5,181. Each trial links to its page on Pharma Observatory.
5,081 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.